OrganaBio Acquires Excellos Operating Assets, Establishing a Coast-to-Coast Cell Therapy Contract Testing, Development and Manufacturing Organization

New organization leverages manufacturing, PBMC isolation, and cryopreservation services across multiple facilities, supporting cell therapy programs from preclinical through commercial supply Core Excellos team retained; existing customer programs to continue without interruption MIAMI — OrganaBio, LLC (“OrganaBio”), a manufacturer of GMP cells and blood products and provider of cell isolation and cryopreservation services, has acquired... The post OrganaBio Acquires Excellos Operating Assets, Establishing a Coast-to-Coast Cell Therapy Contract Testing, Development and Manufacturing Organization appeared first on Montreal Gazette .

Original source: Montreal Gazette